Effects of prolonged metoprolol treatment on neural remodeling and inducible ventricular arrhythmias after myocardial infarction in rabbits.
BACKGROUND
Neural remodeling is part of the pathophysiology of ventricular arrhythmias after myocardial infarction (MI). In this study, we developed a rabbit model of MI to investigate the effect of the beta-blocker metoprolol on ventricular neural remodeling and susceptibility to ventricular arrhythmias.


METHODS
MI was induced by ligation of the left anterior descending coronary artery in 30 rabbits, and sham operations were performed in 12 control animals. Metoprolol was then administered to 15 of the MI animals. After electrophysiological recordings, the expression of nerve markers was studied at the infarct border and the non-infarct left ventricle free wall (LVFW) by immunostaining or RT-PCR.


RESULTS
Eight weeks after MI, the incidence of inducible ventricular arrhythmias was significantly (P<0.01) higher in the MI group than in the sham group. However, metoprolol treatment decreased incidence of post-MI ventricular arrhythmias (8.3%) compared to those without treatment (58.3%, P<0.001). The density of nerve fibers was increased in MI group (3889+/-521 microm(2)/mm(2)) compared to the sham group (1727+/-304 microm(2)/mm(2)). Treatment of MI rabbits with metoprolol resulted in a partial reduction (2725+/-283 microm(2)/mm(2)). However, the shape and imbalance of nerve fibers appeared to be normalized by the metoprolol treatment. The expression levels of TH mRNA were reduced (P<0.01) by metoprolol treatment.


CONCLUSIONS
Metoprolol reduces post-MI ventricular arrhythmias, partly by altering the neural remodeling process.
Yan
Su-Hua
SH
Department of Cardiology, Qianfoshan Hospital of Shandong Province, Jinan, 250014, China. yansuhua5537@163.com
Hu
He-Sheng
HS
Wang
Xing-Li
XL
Xing
Qi-Chong
QC
Wang
Qing
Q
Shi
Chang-Wen
CW
Cheng
Wen-Juan
WJ
Xue
Mei
M
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000209:etiology* / Q000517:prevention & control*; D006352:Heart Ventricles / Q000187:drug effects / Q000294:innervation; D008790:Metoprolol / Q000008:administration & dosage*; D009203:Myocardial Infarction / Q000150:complications*; D011817:Rabbits; D020257:Ventricular Remodeling / Q000187:drug effects*
D000319:Adrenergic beta-Antagonists; D008790:Metoprolol